ArticleLeukemia2025
Impact of discordant revised versus molecular international prognostic scoring system risk in myelodysplastic syndrome.
Alexandre Bazinet et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it